Affiliation:
1. Bioprocess Development, Technical Operations Denali Therapeutics, Inc. South San Francisco California USA
2. Discovery Biology Denali Therapeutics, Inc. South San Francisco California USA
Abstract
AbstractTransposons are genetic elements capable of cutting and pasting genes of interest via the action of a transposase and offer many advantages over random or targeted integration of DNA in the creation of Chinese hamster ovary (CHO) cell lines for recombinant protein expression. Unique transposases have different recognition sites, allowing multiple transposases to be co‐transfected together. They also allow for supertransfection (transfection on a previously transfected pool or cell line) with a second transposase to integrate additional copies of the same gene or an additional gene without disruption of the previously integrated DNA which to our knowledge has not been previously described in literature. Two fluorescent proteins, EGFP and tagRFP657, were either co‐transfected or supertransfected into CHO cells using two unique transposases and showed high expression efficiency with similar expression levels (measured as mean fluorescence intensity), regardless of whether the genes were co‐transfected or supertransfected onto an existing stable pool. Additionally, dual selection of the genes, both in the absence of L‐glutamine and the presence of puromycin, led to higher expression levels than single selection alone. These results demonstrate that supertransfection using unique transposases could be a useful strategy for increasing titers of existing cell lines or for overexpressing helper (non‐therapeutic) genes to improve expression and/or product quality of existing pools and cell lines, potentially saving significant time and resources.